Eli Lilly to raise funds to share drug development costs
Eli Lilly plans to put roughly $50m into each of the three mirror funds containing up to 20 experimental medicines from different therapeutic areas to speed up this
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.